The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
111 ECOZIN-M LEVOCETIRIZINE DIHYDROCHLORIDE USP 5 MG, MONTELUKAST SODIUM USP 10 MG FILM COATED TABLET ALU-ALU BLISTER FOR RELIEF OF SYMPTOMS OF ALLERGIC RHINITIS (SEASONAL AND PERENNIAL) NULL ASA LAO SOLE COMPANY LIMITED IMPULSE PHARMA PVT. LTD INDIA CERTIFICATE RELEASED 04 I 5725/24 2024-04-26 2027-04-25 View
112 ECOZOLE-400 ALBENDAZOLE USP 400 MG CHEWABLE TABLET ALU-PVC BLISTER TREATMENT OF PARENCHYMAL NEUROCYSTICERCOSIS DUE TO ACTIVE LESIONS CAUSED BY LARVAL FORMS OF THE PORK TAPEWORM, TAENIA SOLIUM. TREATMENT OF CYSTIC HYDATID DISEASE OF THE LIVER, LUNG, AND PERITONEUM CAUSED BY THE LARVAL FORM OF THE DOG TAPEWORM, ECHINOCOCCUS GRANULOSUS. NULL ASA LAO SOLE COMPANY LIMITED IMPULSE PHARMA PVT.LTD INDIA CERTIFICATE RELEASED 03 I 5423/23 31-Mar-2023 30-Mar-2026 View
113 ESOPRAZOLE 40 ESOMEPRAZOLE MAGNESIUM EQ.TO ESOMEPRAZOLE USP 40 MG CAPSULE ALU-ALU BLISTER GASTRO-OESOPHAGEAL REFLUX DISEASE, TREATMENT OF EROSIVE REFLUX OESOPHAGITIS, LONG TERM MANAGEMENT OF PATIENTS WITH HEALED OESOPHAGITIS TO PREVENT RELAPSE, SYMPTOMATIC TREATMENT OF GASTRO-OESOPHAGEAL REFLUX DISEASE, HEALING OF GASTRIC ULCERS ASSOCIATED WITH NSAID THERAPY, PREVENTION OF GASTRIC AND DUODENAL ULCERS ASSOCIATED WITH NSAID THERAPY IN PATIENTS AT RISK, HEALING OF HELICOBACTER PYLORI ASSOCIATED DUODENAL ULCER NULL ASA LAO SOLE COMPANY LIMITED IMPULSE PHARMA PVT. LTD INDIA CERTIFICATE RELEASED 01 I 5863/25 31-JAN-2025 30-JAN-2030 View
114 ESOPRAZOLE-20 ESOMEPRAZOLE MAGNESIUM EQ.TO ESOMEPRAZOLE USP 20 MG CAPSULE ALU-ALU BLISTER GASTRO-OESOPHAGEAL REFLUX DISEASE, TREATMENT OF EROSIVE REFLUX OESOPHAGITIS, LONG TERM MANAGEMENT OF PATIENTS WITH HEALED OESOPHAGITIS TO PREVENT RELAPSE, SYMPTOMATIC TREATMENT OF GASTRO-OESOPHAGEAL REFLUX DISEASE, HEALING OF GASTRIC ULCERS ASSOCIATED WITH NSAID THERAPY, PREVENTION OF GASTRIC AND DUODENAL ULCERS ASSOCIATED WITH NSAID THERAPY IN PATIENTS AT RISK, HEALING OF HELICOBACTER PYLORI ASSOCIATED DUODENAL ULCER NULL ASA LAO SOLE COMPANY LIMITED IMPULSE PHARMA PVT. LTD INDIA CERTIFICATE RELEASED 04 I 5726/24 2024-04-26 2027-04-25 View
115 FERROKAM XT TOTAL FERROUS ASCORBATE EQ.TO ELEMENTAL IRON 100 MG, FOLIC ACID BP 1.1 MG, ZINC SULFATE MONOHYDRATE BP EQ.TO ELEMENTAL ZINCE 22.5 MG, METHYLCOBALAMIN 1.5 MG FILM COATED TABLET ALU-ALU BLISTER TO TREAT AND PREVENT NUTRITIONAL DEFICIENCIES SUCH AS IRON DEFICIENCY ANAEMIA NULL ASA LAO SOLE COMPANY LIMITED IMPULSE PHARMA PVT. LTD INDIA CERTIFICATE RELEASED 01 I 5864/25 31-JAN-2025 30-JAN-2030 View
116 GLYCIKAM SR 500 METFORMIN HYDROCHLORIDE BP 500 MG PROLONGED RELEASE TABLET ALU-ALU BLISTER TREATMENT OF TYPE 2 DIABETES MELLITUS IN ADULTS, PARTICULARY IN OVERWEIGHT PATIENTS, WHEN DIETARY MANAGEMENT AND EXCERCISE ALONE DOES NOT RESULT IN ADEQUATE GLYCAEMIC CONTROL, MAY BE USED AS MONOTHERAPY OR IN COMBINATION WITH OTHER ORAL ANTIDIABETIC AGENTS OR WITH INSULIN. NULL ASA LAO SOLE COMPANY LIMITED IMPULSE PHARMA PVT. LTD INDIA CERTIFICATE RELEASED 09 I 5796/24 25-SEP-2024 24-SEP-2029 View
117 GLYCIKAM SR G1 METFORMIN HYDROCHLORIDE BP 500 MG, GLIMEPIRIDE BP 1 MG TABLET ALU-ALU BLISTER AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETE WHO ARE ALREADY TREATED WITH COMBINATION OF GLIMEPIRID AND METFORMIN OR WHOSE DIABETES IS NOT ADEQUATELY CONTROLLED WITH METFORMIN ALONE. NULL ASA LAO SOLE COMPANY LIMITED IMPULSE PHARMA PVT. LTD INDIA CERTIFICATE RELEASED 09 I 5798/24 25-SEP-2024 24-SEP-2029 View
118 GLYCIKAM SR G2 METFORMIN HYDROCHLORIDE BP 500 MG, GLIMEPIRIDE BP 2 MG PROLONGED RELEASE TABLET ALU-ALU BLISTER AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETE WHO ARE ALREADY TREATED WITH COMBINATION OF GLIMEPIRID AND METFORMIN OR WHOSE DIABETES IS NOT ADEQUATELY CONTROLLED WITH METFORMIN ALONE. NULL ASA LAO SOLE COMPANY LIMITED IMPULSE PHARMA PVT. LTD INDIA CERTIFICATE RELEASED 09 I 5797/24 25-SEP-2024 24-SEP-2029 View
119 ITRAKAM 200 ITRACONAZOLE (AS PELLET) 200 MG CAPSULE ALU-ALU BLISTER FOR THE TREATMENT OF THE FOLLOWING FUNGAL INFECTION WHEN THOUGHT LIKELY TO BE SUSCEPTIBLE: VULVOVAGINAL CANDIDIASIS, PITYRIASIS VERSICOLOR, DERMATOPHYTOSE CAUSED BY ORGANISM SUSCEPTIBLE TO ITRACONAZOLE, ORAL CANDIDIASIS, ONYCHOMYCOSIS CAUSED BY DERMATOPHYTE AND /OR YEAST NULL ASA LAO SOLE COMPANY LIMITED IMPULSE PHARMA PVT. LTD INDIA CERTIFICATE RELEASED 01 I 5865/25 31-JAN-2025 30-JAN-2030 View
120 KAMZOLE 200 KETOCONAZOLE USP 200 MG TABLELT ALU-ALU BLISTER TREATMENT FOR CANDIDIASIS, CHRONIC MUCOCUTANEOUS CANDIDIASIS, ORAL THRUSH CANDIDURIA, BLASTOMYCOSIS, COCCIDIOIMYCOSIS, HISTOPLASMOSIS, CHROMOMYCOSIS AND PARACOCCIDIOIDOMYCOSIS. FOR THE TREATMENT WITH SEVERE RECALCITRANT CUTANEOUS DERMATOPHYTE INFECTIONS NULL ASA LAO SOLE COMPANY LIMITED IMPULSE PHARMA PVT.LTD INDIA CERTIFICATE RELEASED 02 I 5189/22 03-MAR-2025 02-MAR-2030 View
 
© 2014 ສະຫງວນລິຂະສິດໂດຍ ກົມອາຫານ ແລະ ຢາ, ກະຊວງສາທາລະນະສຸກ, ສປປລາວ.
ຕິດຕໍ່ ກອຢ      ອີເມວ      ເຂົ້າລະບົບ